Navigation Links
CVS Caremark Study Finds Medication Adherence Leads to Lower Health Care Costs, Even After Accounting for Increased Prescription Drug Spending

WOONSOCKET, R.I., Jan. 6, 2011 /PRNewswire/ -- A new CVS Caremark study analyzing annual pharmacy and medical costs over a three-year period for patients with one or more of four chronic diseases concludes that patients who take medications as doctors direct may save the health care system as much as $7,800 per patient annually.  The study findings revealed robust reductions in emergency department visits and inpatient hospital days from medication adherence and by avoiding those costly events there were substantial savings in overall health care costs.  The study, "Medication Adherence Leads to Lower Health Care Use and Costs Despite Increased Drug Spending," was released today in the January issue of Health Affairs.


Troyen A. Brennan, MD, MPH, Executive Vice President and Chief Medical Officer of CVS Caremark and a study author, said company researchers analyzed pharmacy and medical claims data of 135,000 patients with congestive heart failure, diabetes, hypertension and dyslipidemia to determine the direct effect of adherence on costs.

"There have been many studies through the years that suggest adherence can save on health care costs, but the issue has not been central to health care cost discussions because those studies did not establish a causal link. We took the research further and what we found is that although adherent patients spend more on medications – as much as $1,000 more annually – across the board they spend significantly less for their overall health care costs," Brennan said.

The annual per person savings for chronically ill patients who were adherent to medications compared to those who were not amounted to $7,823 for those with congestive heart failure, $3,756 for a diabetes patient, $3,908 for hypertension and $1,258 for dyslipidemia or high cholesterol. Brennan said CVS Caremark plans to share the study with health care regulators and federal legislators as they consider policies to reduce health care costs.

The study population included patients in the CVS Caremark book of business with congestive heart failure (16,353), diabetes (42,080), hypertension (112,757) and dyslipidemia (53,401). "Across all conditions, adherence was associated with significantly lower annual inpatient hospital days," the study found.

Among the disease specific findings are:

  • People with congestive heart failure spent $39,076 on average annually, and had an average of 11.9 days in the hospital.  Those with congestive heart failure were older, averaging 77 years of age.
  • Diabetes costs per patient on average were $17,955 annually and these patients had an average of 4.26 days in the hospital.
  • Hypertension patients spent $14,813 on average annually and had 3.29 days on average in the hospital.
  • The annual spend for a person being treated for dyslipidemia was $12,688 on average. Hospital stays for these patients were 2.24 days on average.

  • Pharmacy costs for the patients ranged from $2,867 to $3,780 per year.

    The researchers also found that adherence effects were more pronounced in elderly patients sixty-five years and older. They commented that changes in the recently passed health reform law for Medicare, reducing prescription costs for beneficiaries by eliminating the doughnut hole and providing for therapy management and wellness programs, "were prudent." They recommend policy analysts take a harder look at how adherence programs and incentives might bend the health care cost curve downward.

    "No matter what the intervention, the researchers agreed that actively encouraging medication adherence for chronic disease should be a top priority," noted M. Christopher Roebuck, director of strategic research for CVS Caremark and lead author of the study. "Despite higher pharmacy spending the reduction in hospitalizations and emergency room use resulted in substantial savings."

    About CVS CaremarkCVS Caremark is the largest pharmacy health care provider in the United States. Through our integrated offerings across the entire spectrum of pharmacy care, we are uniquely positioned to provide greater access, to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of more than 64,000 pharmacies, including approximately 7,100 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical expertise includes one of the industry's most comprehensive disease management programs. General information about CVS Caremark is available through the Company's Web site at Contact:Jon SandbergCVS Caremark(401)770

    SOURCE CVS Caremark
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year
    2. CVS Caremark Data Confirms Improved Outcomes for Women with Osteoporosis Who are Adherent to Therapy
    3. CVS Caremark Launches Distribution of $3 million in Free Seasonal Flu Shot Vouchers to the Unemployed
    4. CVS Caremark Celebrates Outstanding Pharmacy Care to Patients During American Pharmacists Month in October
    5. CVS Caremark Undertakes Multi-Year Study to Improve Patient Medication Adherence
    6. CVS Caremark Announces Updates to Flu Vaccine Program
    7. CVS Caremarks MinuteClinic and Allina Hospitals & Clinics Form Strategic Partnership
    8. CVS Caremark Corporation Increases Quarterly Dividend 15%
    9. CVS Caremarks MinuteClinic Becomes First Retail Clinic Provider to Achieve Consecutive Accreditation Awards From The Joint Commission
    10. CVS Caremark Names New Chief Human Resources Officer
    11. CVS Caremark Corporation Announces Quarterly Dividend
    Post Your Comments:
    (Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
    (Date:11/25/2015)... 25, 2015 Kitov Pharma ... KTOV), a biopharmaceutical company focused on the development of ... conditions, today announced the closing of its previously announced ... ADSs ), each representing 20 ordinary shares of the ... The ADSs and warrants were issued in a fixed ...
    (Date:11/25/2015)... DIEGO , Nov. 25, 2015  Today AVACEN Medical announced the issue of ... Thermal Energy Including Blood Viscosity Adjustment ". This patent shields the company,s AVACEN 100 dry heat ... Treatment Method. Photo - ... ... ...
    Breaking Medicine Technology:
    (Date:11/25/2015)... ... 25, 2015 , ... Lakeview Health, a Jacksonville-based drug and ... sobriety and show through pictures what a positive difference it makes. The social ... the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short stories ...
    (Date:11/25/2015)... , ... November 25, 2015 , ... The McHenry County ... recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. ... Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, ...
    (Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new Android ... The new app features a more intuitive SleepScore™ that rates sleep quality on a ... The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to provide ...
    (Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk Driving (MADD) ... below 10,000 for the first time since 2011. In 2014, there were 9,967 fatalities ... released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in ...
    (Date:11/25/2015)... ... 2015 , ... Privately owned Contract Development and Manufacturing Organization ... current state of the art research, development and manufacturing facility outside of Fort ... capacity as well as to support its clients’ growing research and development and ...
    Breaking Medicine News(10 mins):